Anti-<i>Pseudomonas aeruginosa</i> Vaccines and Therapies: An Assessment of Clinical Trials

Anti-<i>Pseudomonas aeruginosa</i> Vaccines and Therapies: An Assessment of Clinical Trials

<i>Pseudomonas aeruginosa</i> is a Gram-negative opportunistic pathogen that causes high morbidity and mortality in cystic fibrosis (CF) and immunocompromised patients, including patients with ventilator-associated pneumonia (VAP), severely burned patients, and patients with surgical wou...

Full description

Bibliographic Details
Main Authors:	Moamen M. Elmassry, Jane A. Colmer-Hamood, Jonathan Kopel, Michael J. San Francisco, Abdul N. Hamood
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Microorganisms
Subjects:	ventilator-associated pneumonia clinical trials vaccines cystic fibrosis chronic lung infection antibiotics
Online Access:	https://www.mdpi.com/2076-2607/11/4/916

Similar Items

Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment
by: Céline Lucchetti-Miganeh, et al.
Published: (2014-04-01)

<em>Pseudomonas aeruginosa</em>: Recent Advances in Vaccine Development
by: Matthew Killough, et al.
Published: (2022-07-01)

Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial
by: Arnaud Foucrier, et al.
Published: (2023-05-01)

Sub-Inhibitory Antibiotic Exposure and Virulence in <i>Pseudomonas aeruginosa</i>
by: Charlotte Nolan, et al.
Published: (2021-11-01)

β-lactam Resistance in <i>Pseudomonas aeruginosa</i>: Current Status, Future Prospects
by: Karl A. Glen, et al.
Published: (2021-12-01)

Lung and Gut Microbiota Changes Associated with <i>Pseudomonas aeruginosa</i> Infection in Mouse Models of Cystic Fibrosis
by: Giovanni Bacci, et al.
Published: (2021-11-01)

<i>Pseudomonas aeruginosa</i>: Infections, Animal Modeling, and Therapeutics
by: Stephen J. Wood, et al.
Published: (2023-01-01)

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021-07-01)

During bacteremia, Pseudomonas aeruginosa PAO1 adapts by altering the expression of numerous virulence genes including those involved in quorum sensing.
by: Kellsie L Beasley, et al.
Published: (2020-01-01)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

How to manage Pseudomonas aeruginosa infections
by: Matteo Bassetti, et al.
Published: (2018-05-01)

The In Vivo and In Vitro Assessment of Pyocins in Treating <i>Pseudomonas aeruginosa</i> Infections
by: Abdulaziz Alqahtani, et al.
Published: (2022-10-01)

Comparison of virulence factors and antibiotic resistance of Pseudomonas aeruginosa strains isolated from patients with and without cystic fibrosis
by: Macin Salih, et al.
Published: (2017-10-01)

<i>Pseudomonas aeruginosa</i> <i>mexR</i> and <i>mexEF</i> Antibiotic Efflux Pump Variants Exhibit Increased Virulence
by: Mylene Vaillancourt, et al.
Published: (2021-09-01)

Effects of Levofloxacin, Aztreonam, and Colistin on Enzyme Synthesis by <i>P. aeruginosa</i> Isolated from Cystic Fibrosis Patients
by: Arianna Pani, et al.
Published: (2022-08-01)

Involvement of Acquired Tobramycin Resistance in the Shift to the Viable but Non-Culturable State in <i>Pseudomonas aeruginosa</i>
by: Gianmarco Mangiaterra, et al.
Published: (2023-07-01)

Pseudomonas aeruginosa ventilator-associated pneumonia management
by: Ramírez-Estrada S, et al.
Published: (2016-01-01)

The global epidemiology of ventilator-associated pneumonia caused by multi-drug resistant Pseudomonas aeruginosa: A systematic review and meta-analysis
by: Yixuan Li, et al.
Published: (2024-02-01)

Predicting Antibiotic-Associated Virulence of Pseudomonas aeruginosa Using an ex vivo Lung Biofilm Model
by: Marwa M. Hassan, et al.
Published: (2020-09-01)

The role of hypermutation and collateral sensitivity in antimicrobial resistance diversity of Pseudomonas aeruginosa populations in cystic fibrosis lung infection
by: Jelly Vanderwoude, et al.
Published: (2024-02-01)

To bead or not to bead: A review of Pseudomonas aeruginosa lung infection models for cystic fibrosis
by: Nicole Reyne, et al.
Published: (2023-02-01)

Pseudomonas aeruginosa in tracheal aspirate: Colonization, infection, and recurrence
by: Larissa Hermann deSouza Nunes, et al.
Published: (2023-05-01)

Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis
by: Beverley Cherie Millar, et al.
Published: (2021-01-01)

INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care—study protocol for a multicentre randomised controlled trial
by: Juliet High, et al.
Published: (2021-10-01)

Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa
by: Ronan A. Murphy, et al.
Published: (2022-08-01)

The Antibiotic Resistance Genes blaSHV, blaOXA-48, blaTEM and blaIMP in Pseudomonas aeruginosa Isolated from Respiratory Tract Infections in Baghdad, Iraq
by: Hasan A. Aal Owaif, et al.
Published: (2023-12-01)

Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
by: Diana L. Wells, et al.
Published: (2013-07-01)

Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in <italic toggle="yes">Pseudomonas aeruginosa</italic>
by: Peter Jorth, et al.
Published: (2017-11-01)

Persistence and Microevolution of Pseudomonas aeruginosa in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study
by: Irene Bianconi, et al.
Published: (2019-01-01)

Different Dose-Dependent Modes of Action of C-Type Natriuretic Peptide on Pseudomonas aeruginosa Biofilm Formation
by: Florie Desriac, et al.
Published: (2018-04-01)

Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia
by: Emel Sen-Kilic, et al.
Published: (2019-10-01)

Bioenergetics of the polyphosphates accumulation in Pseudomonas aeruginosa via polyphosphate kinase activation by choline in a lung colonization model
by: Alejandro Rossi, et al.
Published: (2023-02-01)

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i> Infections in Cystic Fibrosis
by: Danni Li, et al.
Published: (2023-02-01)

Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia
by: Aisling R. Caffrey, et al.
Published: (2022-07-01)

Lung transplantation for cystic fibrosis complicated by cirrhosis: A case report
by: Miho Yamaguchi, et al.
Published: (2023-01-01)

Characterization of biofilm-like structures formed by <it>Pseudomonas aeruginosa</it> in a synthetic mucus medium
by: Haley Cecily L, et al.
Published: (2012-08-01)

Detection of <it>Pseudomonas aeruginosa</it> in sputum headspace through volatile organic compound analysis
by: Goeminne Pieter C, et al.
Published: (2012-10-01)

Combined Bacteriophage and Antibiotic Treatment Prevents Pseudomonas aeruginosa Infection of Wild Type and cftr- Epithelial Cells
by: Alexandre Luscher, et al.
Published: (2020-08-01)

Effectiveness of a multistep Pseudomonas aeruginosa eradication treatment protocol in children with cystic fibrosis in Brazil
by: Barbara Riquena, et al.
Published: (2020-07-01)

Acidic Microenvironment Determines Antibiotic Susceptibility and Biofilm Formation of Pseudomonas aeruginosa
by: Qiao Lin, et al.
Published: (2021-11-01)